REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCizzle Biotech Share News (CIZ)

Share Price Information for Cizzle Biotech (CIZ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.775
Bid: 1.70
Ask: 1.85
Change: 0.00 (0.00%)
Spread: 0.15 (8.824%)
Open: 1.775
High: 1.775
Low: 1.775
Prev. Close: 1.775
CIZ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Ceiba net asset value down, up for Asia Dragon Trust

Thu, 27th Apr 2023 17:02

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Ceiba Investments Ltd - investment firm dedicated to investing in Cuba, with interests in the commercial and tourism real estate sectors - Net asset value per share on December 31 is USD1.03, down from USD1.16 a year earlier. Net loss to shareholders of parent company in 2022 is USD14.3 million, narrowed from USD28.8 million. To internalise investment management and end abrdn Fund Managers Ltd agreement. Says lead fund manager Sebastian Berger to move to Ceiba from abrdn and become Ceiba chief executive officer. Says Berger will move with existing management.

----------

Mobile Tornado Group PLC - Harrogate, England-based communications company - Pretax loss in 2022 widens to GBP1.4 million from GBP861,000 a year earlier. Revenue falls to GBP2.3 million from GBP2.6 million. Predicts "material uplift" in 2023 financial performance.

----------

Asia Dragon Trust PLC - Edinburgh, Scotland-based investor in Asian equity markets - NAV per share at February 28 is 469.24 pence from 513.32p on August 31. Says second half NAV total return is negative 7.2%, underperforming the MSCI AC Asia (ex Japan) Index, which had a total return of negative 5.7%. Half-year loss on investments narrows to GBP44.9 million from GBP53.5 million a year earlier. Expects improved earnings for its portfolio companies, arguing the "end of China's strict 'zero-Covid' policy raised hopes of the start of an economic recovery and Asia continued to be supported by strong, long-term structural drivers".

----------

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Pretax loss in 2022 narrows to GBP963,000 from GBP4.0 million in 2021. Recognises no revenue in 2022, unchanged from 2021. Executive Chair Allan Syms says: "The group has continued throughout 2022 in developing a blood test for the early detection of lung cancer [...] The board intends for the group's initial product to be a diagnostic immunoassay that can be readily performed by hospitals and reference laboratories, but a potential follow-on product could be a point of care test provided by a primary health care provider. Throughout 2022, the company continued to work with external expert partners and suppliers to develop and supply of proprietary key monoclonal antibodies and other detector proteins for its assay platform."

----------

Panther Metals PLC - Canada and Australia-focused mineral exploration company - Pretax loss in 2022 widens to GBP952,896 from GBP126,269 in 2021. Reports no revenue in 2022, unchanged from 2021. Non-Executive Chair Nicholas O'Reilly says: "We are advancing various strategies to add value to the portfolio, such that component parts may achieve self-sustainability and in which Panther will retain a significant position, through joint ventures, partial divestment in subsidiaries or even project sales. Your board is committed to finding ways to add maximum value within the shortest possible time frame and accordingly is forever on the lookout for opportunities to develop and enhance the project pipeline of the company."

----------

Mosman Oil & Gas Ltd - New South Wales, Australia-based oil exploration, development and production company - Secures 78% working interest in lease next to its Cinnabar lease in Texas, US. Will pay USD36,000 plus 25% royalty on gross production for the 18 month lease. Says lease can be extended by drilling and production of a well.

----------

Mattioli Woods PLC - Leicester, England-based wealth and asset manager - Acquires 50.1% majority stake in White Mortgages Ltd for GBP425,000. Also enters into an option agreement with the seller Mark Sutton and Robert White to acquire the remaining 49.9% of White mortgages. The call option is exercisable via payment of GBP2.6 million at any time within the two years following April 27, 2026. Mattioli Woods Group Managing Director says: "Our investment in White Mortgages is an exciting extension to our existing client proposition and is another step forward for Mattioli Woods as we continue to expand our operations. Over the past six-months we have seen significant changes in the economy, none more so than immediately after the government's mini-budget last September and the impact it had on the mortgage market, with a leap in mortgage interest rates, the withdrawal of many mortgage products and a rapid tightening in lenders' underwriting criteria."

----------

Seed Innovations Ltd - AIM-listed investor in the medical cannabis, health, and wellness space - Says portfolio company Little Green Pharma Ltd has cash receipts at the end of the quarter on March 31 of USD6.7 million, up from USD6.0 million from the previous quarter. Seed Innovations Vice President of Investment Analysis Alfredo Pascual says: "[These results] are worth highlighting, especially when compared to other non-North American cannabis operators. Moreover, having AUD12.4 million cash in the bank (prior to post quarter Canopy loan repayment) and a now unencumbered Danish facility positions the company in a unique opportunity to capitalize on the growth of medical cannabis markets in Europe and Australia."

----------

Galantas Gold Corp - owns Omagh open pit gold mine in Country Tyrone, Northern Ireland - Completes a shares-for-debt transaction with several "arm's length" creditors of the company, settling around CAD750,000 of indebtedness through the issue of 2.1 million shares at a price of CAD0.36 per share.

----------

Resolute Mining Ltd - Perth, Australia-based gold miner, developer, and explorer with more than 30 years of experience across Australia and Africa - Says gold poured in the first quarter of 2023 up 1% to 92,259 ounces from a year earlier. Gold sold falls 6% to 88,151 ounces, while ore processed is down 4% to 1.5 million tonnes. Chief Executive Officer Terry Holohan says: ""I am pleased to report another solid quarter for Resolute, recording a sixth consecutive increase in production with 92,259 ounces of gold poured, underpinned by improved productivity at all three mines (Syama Sulphide, Syama Oxide and Mako). This is a significant achievement especially given the pre-planned seven day downtime for roaster maintenance at the Syama Sulphide operations, towards the end of the quarter [...] the company's focus for the remainder of 2023 at Mako is on the planned pit extension, with mining for the remainder of the year through a lower grade section. The company expects the June and September quarterly production levels to decrease marginally as the operations move through this section of the pit. Once the extension is complete, operations at Mako will return to the higher grade ore and benefit from lower stripping ratios, thus enabling higher production for the remainder of the mining life, out to 2025."

----------

Driver Group PLC - Lancashire, England-based professional services consultancy to construction and engineering industries - Expects pretax profit in the first half that ended March 31 of GBP650,000, up from GBP400,000 a year earlier. Expects revenue of GBP24.2 million, narrowly down from GBP24.4 million. Chief Executive Officer Mark Wheeler says: "Our staff around the world have worked tirelessly with management to move the business forward, in line with the plans we set out for FY23. As we move into the second half of FY23, we are encouraged by the opportunities and progress made, building on the sound foundations we have established."

----------

By Greg Rosenvinge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
23 Dec 2022 18:15

TRADING UPDATES: Fiinu teams with TransUnion; GRC wins pact

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
23 Nov 2022 16:58

IN BRIEF: Cizzle Biotechnology signs lung-cancer study in China

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Signs further Memorandum of Understanding with International Co-Innovation Centre for Advanced Medical Technology for a clinical pilot study with the Cancer Hospital Chinese Academy of Medical Sciences, National Cancer Center of China. The clinical pilot study will evaluate optimised assays using a monoclonal antibody that Cizzle Biotechnology has developed that specifically detects CIZ1B, which is highly associated with stage 1 lung cancer.

Read more
9 Nov 2022 20:41

UPDATE: Cizzle, Vela Technologies notes planned Conduit Pharma merger

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - and Vela Technologies PLC - Bradford, England-based investment firm focused on early-stage and pre-IPO disruptive technology investments - Notes announcement by Conduit Pharmaceuticals Ltd that it intends to become a publicly traded company on the Nasdaq in the US through a merger with special purpose acquisition firm Murphy Cannon Acquisition Corp. The deal is expected to generate USD149.7 million worth of proceeds for Conduit.

Read more
28 Sep 2022 14:43

Cizzle Biotechnology reports narrowed loss as passes "key milestones"

(Alliance News) - Cizzle Biotechnology Holdings PLC on Wednesday said it had passed "key milestones" as it moved towards generating revenue for its products.

Read more
18 Aug 2022 11:37

Vela Tech, Cizzle Biotech shares jump on investee's trial results

(Alliance News) - Vela Technologies PLC and Cizzle Biotechnology Holdings PLC on Thursday hailed the latest clinical trial results from investee St George Street Capital Ltd.

Read more
5 Jul 2022 12:15

Cizzle Biotechnology expands use of lung cancer test

(Alliance News) - Cizzle Biotechnology Holdings PLC on Tuesday said that it is using its early-stage lung cancer test technology to detect more cancer types, notably breast cancer.

Read more
20 Jun 2022 15:40

UK shareholder meetings calendar - next 7 days

Tuesday 21 June 
1Spatial PLCAGM
Altus Strategies PLCAGM
Coca-Cola HBC AGAGM
FireAngel Safety Technology Group PLCAGM
HC Slingsby PLCAGM
HSS Hire Group PLCAGM
Mission Group PLCAGM
Novacyt SAAGM
Pendragon PLCAGM
RTW Venture Fund LtdAGM
Velocys PLCAGM
Wednesday 22 June 
ASA International Group PLCAGM
Atalaya Mining PLCAGM
Bonhill Group PLCAGM
Chapel Down Group PLCAGM
Churchill China PLCAGM
Downing Renewables & Infrastructure Trust PLCGM re share issue
Ecofin US Renewables Infrastructure Trust PLCAGM
EJF Investments LtdAGM
Frenkel Topping Group PLCAGM
Good Energy Group PLCAGM
Honeycomb Investment Trust PLCAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Intelligent Ultrasound Group PLCAGM
Iofina PLCAGM
John Wood Group PLCAGM
Kingfisher PLCAGM
LXi REIT PLCGM
Menhaden PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Pennant International Group PLCAGM
Plant Health Care PLCAGM
Skillcast Group PLCAGM
Team PLCAGM
Tribal Group PLCGM re final dividend
Trident Royalties PLCAGM
Vertu Motors PLCAGM
Wentworth Resources PLCAGM
Thursday 23 June 
Avacta Group PLCAGM
Anglo Asian Mining PLCAGM
Card Factory PLCAGM
Cordiant Digital Infrastructure LtdAGM
Downing Renewables & Infrastructure Trust PLCGM re initial placing & open offer
Eight Capital Partners PLCGM re aligning 2022 bonds with 2026 bonds
GENinCode PLCAGM
Ideagen PLCGM re takeover by Hg Pooled Management Ltd
Longboat Energy PLCAGM
Oxford Nanopore Technologies PLCAGM
Puma VCT 13 PLCGM re cancellation of listing & liquidation
RBG Holdings PLCAGM
Tandem Group PLCAGM
Union Jack Oil PLCAGM
Zinnwald Lithium PLCAGM
Friday 24 June 
AFC Energy PLCGM re fees for non-executive directors
Avast PLCAGM
Devolver Digital IncAGM
Entain PLCAGM
Gulf Keystone Petroleum LtdAGM
Hawkwing PLCAGM
Invesco Bond Income Plus LtdAGM
Life Science REITAGM
Northcoders Group PLCAGM
Princess Private Equity Holding LtdAGM
Monday 27 June 
Anglo-Eastern Plantations PLCAGM
Celadon Pharmaceuticals PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Echo Energy PLCAGM
Medica Group PLCAGM
Pelatro PLCAGM
Surgical Innovations Group PLCAGM
Warpaint London PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
16 Jun 2022 16:55

TRADING UPDATES: Valereum opens NFT market; Conygar considers raising

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
30 May 2022 12:32

IN BRIEF: Cizzle Biotechnology widens annual loss on acquisition costs

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Posts higher annual loss in 2021. Pretax loss widens to GBP4.0 million from GBP14,000 in 2020. In May 2021, Cizzle was bought by Bould Opportunities PLC. Acquisition-related costs stand at GBP3.1 million in 2021 versus none in 2020.

Read more
6 May 2022 11:18

AIM WINNERS & LOSERS: SDI upbeat; Westminster rises on contract win

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
6 May 2022 10:11

Cizzle Biotechnology shares jump on US lung cancer collaboration

(Alliance News) - Cizzle Biotechnology Holdings PLC on Friday announced a new collaboration into lung cancer testing with a US partner.

Read more
11 Apr 2022 21:14

TRADING UPDATES: WANdisco bookings up; STM legal appeal denied

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
8 Mar 2022 06:45

IN BRIEF: Cizzle Biotech notes promising data from Arcadia study

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Reports that Arcadia clinical study shows potential value of AZD1656 treatment for Covid-19 patients. The new data analysis comes from St George Street Capital Ltd, which runs the trial with Excalibur Medicines Ltd for the treatment, in which Cizzle holds a "significant" royalty-bearing economic interest.

Read more
14 Feb 2022 15:26

Cizzle Biotechnology acquires further 5% interest in Covid treatment

(Alliance News) - Cizzle Biotechnology Holdings PLC shares jumped on Monday after it announced that it acquired an additional 5% interest in the commercialisation of the Covid-19 treatment AZD 1656.

Read more
3 Feb 2022 22:31

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.